The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials |
Rheumatol Ther. 2022 Aug;9(4):1181-1191. doi: 10.1007/s40744-022-00449-6.Epub 2022 May 23.
Philip Mease 1, Arthur Kavanaugh 2, Dafna Gladman 3 4, Oliver FitzGerald 5, Enrique R Soriano 6, Peter Nash 7, Dai Feng 8, Apinya Lertratanakul 8, Kevin Douglas 8, Ralph Lippe 9, Laure Gossec 10 11 |
| 2 | |
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis |
Br J Dermatol. 2022 Sep;187(3):438-441. doi: 10.1111/bjd.21233.Epub 2022 Jun 7.
Kristian Reich 1, Xenophon Baraliakos 2, Laura C Coates 3, Boni Elewski 4, Weibin Bao 5, Torben Kasparek 6, Corine Gaillez 6, Effie Pournara 6, Maher Aassi 6, Chiara Perella 6, Alice B Gottlieb 7 |
| 3 | |
Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis |
Ann Rheum Dis. 2022 Aug 16;annrheumdis-2022-222537. doi: 10.1136/ard-2022-222537.Online ahead of print.
Timothy S H Kwok 1, Mitchell Sutton 2, Daniel Pereira 2, Richard J Cook 3, Vinod Chandran 2 4, Nigil Haroon 1 5, Robert D Inman 1 6, Dafna D Gladman 7 2 |
| 4 | |
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study |
Ann Rheum Dis. 2022 Aug 3;annrheumdis-2022-222562. doi: 10.1136/ard-2022-222562.Online ahead of print.
Fabian Proft 1, Susanne Lüders 2, Theresa Hunter 3, Gustavo Luna 4, Valeria Rios Rodriguez 5, Mikhail Protopopov 1, Katharina Meier 6, Georgios Kokolakis 6, Kamran Ghoreschi 6, Denis Poddubnyy 7 |
| 5 | |
Women with Psoriatic Arthritis Experience Higher Disease Burden than Men: Findings from a Real-World Survey in the USA and Europe |
J Rheumatol. 2022 Aug 15;jrheum.220154. doi: 10.3899/jrheum.220154. Online ahead of print.
Laure Gossec 1, Jessica A Walsh 1, Kaleb Michaud 1, Steve Peterson 1, Elizabeth A Holdsworth 1, Chetan S Karyekar 1, Nicola Booth 1, Soumya D Chakravarty 1, Alexis Ogdie 1 |
| 6 | |
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries |
Arthritis Care Res (Hoboken). 2022 Jul;74(7):1205-1218.doi: 10.1002/acr.24560. Epub 2022 Apr 29.
Brigitte Michelsen 1, Stylianos Georgiadis 2, Daniela Di Giuseppe 3, Anne G Loft 4, Michael J Nissen 5, Florenzo Iannone 6, Manuel Pombo-Suarez 7, Herman Mann 8, Ziga Rotar 9, Kari K Eklund 10, Tore K Kvien 11, Maria J Santos 12, Bjorn Gudbjornsson 13, Catalin Codreanu 14, Sema Yilmaz 15, Johan K Wallman 16, Cecilie H Brahe 17, Burkhard Möller 18, Ennio G Favalli 19, Carlos Sánchez-Piedra 20, Lucie Nekvindova 21, Matija Tomsic 9, Nina Trokovic 10, Eirik K Kristianslund 11, Helena Santos 22, Thorvardur J Löve 23, Ruxandra Ionescu 14, Yavuz Pehlivan 24, Gareth T Jones 25, Irene van der Horst-Bruinsma 26, Lykke M Ørnbjerg 17, Mikkel Østergaard 27, Merete L Hetland 28 |
| 7 | |
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination |
Clin Exp Rheumatol. 2022 Jul;40(7):1432-1441.doi: 10.55563/clinexprheumatol/0jdyse. Epub 2021 Dec 7.
James Galloway 1, Tim Raine 2, Lucy Rivett 2, Jacqueline Roberts 3, Sally-Anne Dews 3, Ernest H Choy 4 |
| 8 | |
Safety and Efficacy of Bimekizumab in Patients with Active Psoriatic Arthritis: 3-Year Results from a Phase 2b Randomized Controlled Trial and its Open-Label Extension Study |
Arthritis Rheumatol. 2022 Jul 13. doi: 10.1002/art.42280. Online ahead of print.
Laura C Coates 1, Iain B McInnes 2, Joseph F Merola 3, Richard B Warren 4, Arthur Kavanaugh 5, Alice B Gottlieb 6, Laure Gossec 7 8, Deepak Assudani 9, Rajan Bajracharya 9, Jason Coarse 10, Barbara Ink 9, Christopher T Ritchlin 11 |
| 9 | |
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE |
Rheumatology (Oxford). 2022 Jul 5;keac353. doi: 10.1093/rheumatology/keac353.Online ahead of print.
Philip J Mease 1, Akihiko Asahina 2, Dafna D Gladman 3, Yoshiya Tanaka 4, William Tillett 5, Barbara Ink 6, Deepak Assudani 6, Christine de la Loge 7, Jason Coarse 8, Jason Eells 6, Laure Gossec 9 10 |
| 10 | |
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial |
RMD Open. 2022 Jul;8(2):e002366. doi: 10.1136/rmdopen-2022-002366.
Philip S Helliwell 1, Phillip J Mease 2, Arthur Kavanaugh 3, Laura C Coates 4, Alexis Ogdie 5, Atul Deodhar 6, Vibeke Strand 7, Gregory Kricorian 8, Lyrica X H Liu 9, David Collier 8, Dafna D Gladman 10 |
| 11 | |
Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort |
Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2225. Online ahead of print.
T W Van Hal 1, M L M Mulder, M H Wenink, M C Pasch, F H J Van den Hoogen, Juul M P A Van den Reek, Elke M G J De Jong |
| 12 | |
Axial psoriatic arthritis and ankylosing spondylitis: same or different? A real-world study with emphasis on comorbidities |
Clin Exp Rheumatol. 2022 Jul;40(7):1267-1272. doi: 10.55563/clinexprheumatol/8zn9z8.Epub 2021 Jul 24.
George E Fragoulis 1, Maria Pappa 2, Gerasimos Evangelatos 2, Alexios Iliopoulos 3, Petros P Sfikakis 2, Maria G Tektonidou 2 |
| 13 | |
Investigation into the wait time for consultation in the psoriatic arthritis program |
Clin Rheumatol. 2022 Jul 22. doi: 10.1007/s10067-022-06288-8. Online ahead of print.
Seiwon Park 1, Orli M Silverberg 1, Elham Moez 2 3, Vinod Chandran 4, Dafna D Gladman 5 6 |
| 14 | |
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2022 Jul;49(7):700-706. doi: 10.3899/jrheum.211033. Epub 2022 Apr 15.
Philip J Mease 1, Taylor Blachley 2, Blessing Dube 2, Robert R McLean 2, Nina Kim 3, Peter Hur 4, Alexis Ogdie 5 |
| 16 | |
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis |
Dermatol Ther (Heidelb). 2022 Jul 21. doi: 10.1007/s13555-022-00770-6. Online ahead of print.
George Gondo 1, Megan Mosca 2, Julie Hong 2, Emanual Maverakis 3, Joseph F Merola 4, April W Armstrong 5, Tina Bhutani 2, Stacie J Bell 6, Wilson Liao 7 |
| 17 | |
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 |
Nat Rev Rheumatol. 2022 Jun 27;1-15. doi: 10.1038/s41584-022-00798-0.Online ahead of print.
Laura C Coates 1, Enrique R Soriano 2, Nadia Corp 3, Heidi Bertheussen 4, Kristina Callis Duffin 5, Cristiano B Campanholo 6, Jeffrey Chau 7, Lihi Eder 8, Daniel G Fernández-Ávila 9, Oliver FitzGerald 10, Amit Garg 11, Dafna D Gladman 12, Niti Goel 13, Philip S Helliwell 14, M Elaine Husni 15, Deepak R Jadon 16, Arnon Katz 17, Dhruvkumar Laheru 18, John Latella 19, Ying-Ying Leung 20, Christine Lindsay 21, Ennio Lubrano 22, Luis Daniel Mazzuoccolo 23, Philip J Mease 24, Denis O'Sullivan 25, Alexis Ogdie 26, Wendy Olsder 27, Penelope Esther Palominos 28, Lori Schick 29, Ingrid Steinkoenig 30, Maarten de Wit 31, D A van der Windt 3, Arthur Kavanaugh 32, |
| 18 | |
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2 |
RMD Open. 2022 Jun;8(2):e002286. doi: 10.1136/rmdopen-2022-002286.
Andrew J K Ostor 1, Ahmed M Soliman 2, Kim A Papp 3, Byron Padilla 2, Zailong Wang 2, Ann Eldred 2, Kurt de Vlam 4, Alan Kivitz 5 |
| 19 | |
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure |
Ann Rheum Dis. 2022 Jul;81(7):944-950.doi: 10.1136/annrheumdis-2021-222027. Epub 2022 Apr 7.
Atul A Deodhar 1, Bernard Combe 2, Ana P Accioly 3, Rebecca Bolce 4, Danting Zhu 3, Amanda M Gellett 3, Aubrey Trevelin Sprabery 3, Gerd-Rüdiger R Burmester 5 |
| 21 | |
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis |
J Rheumatol. 2022 Jul;49(7):694-699. doi: 10.3899/jrheum.210906.Epub 2022 Apr 15.
Philip J Mease 1, Arthur Kavanaugh 2, Alexis Ogdie 3, Alvin F Wells 4, Martin Bergman 5, Dafna D Gladman 6, Sven Richter 7, Lichen Teng 7, Shauna Jardon 7, Josef S Smolen 8 |
| 22 | |
Psoriatic arthritis: Ultrasound peculiarities with particular emphasis on enthesitis |
J Clin Ultrasound. 2022 May;50(4):556-560. doi: 10.1002/jcu.23170.Epub 2022 Mar 2.
Ferdinando Draghi 1 2, Guia Ferrozzi 3 4, Daniela Ballerini 5, Chandra Bortolotto 5 |
| 23 | |
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis |
J Dermatolog Treat. 2022 Jun;33(4):1907-1915.doi: 10.1080/09546634.2021.1942423. Epub 2021 Jun 28.
|
| 24 | |
Psoriatic arthritis from a mechanistic perspective |
Nat Rev Rheumatol. 2022 Jun;18(6):311-325. doi: 10.1038/s41584-022-00776-6.Epub 2022 May 5.
Georg Schett 1 2, Proton Rahman 3, Christopher Ritchlin 4, Iain B McInnes 5, Dirk Elewaut 6, Jose U Scher 7 |
| 25 | |
New Insights on Juvenile Psoriatic Arthritis |
Front Pediatr. 2022 May 26;10:884727. doi: 10.3389/fped.2022.884727.eCollection 2022.
Francesco Brunello 1, Francesca Tirelli 1, Luca Pegoraro 1, Filippo Dell'Apa 1, Alessandra Alfisi 1, Giulia Calzamatta 1, Camilla Folisi 1, Francesco Zulian 1 |
| 26 | |
Apremilast Use in Oligoarticular Psoriatic Arthritis |
J Rheumatol. 2022 Jun 1;jrheum.211227. doi: 10.3899/jrheum.211227. Online ahead of print.
|
| 27 | |
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials |
Rheumatol Ther. 2022 Apr;9(2):521-539. doi: 10.1007/s40744-021-00410-z. Epub 2021 Dec 30.
Gerd R Burmester 1, Kevin Winthrop 2, Ricardo Blanco 3, Peter Nash 4, Philippe Goupille 5, Valderilio F Azevedo 6, Carlo Salvarani 7, Andrea Rubbert-Roth 8, Elizabeth Lesser 9, Ralph Lippe 10, Apinya Lertratanakul 9, Reva M Mccaskill 9, John Liu 9, Eric M Ruderman 11 |
| 28 | |
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries |
Semin Arthritis Rheum. 2022 Apr;53:151979. doi: 10.1016/j.semarthrit.2022.151979.Epub 2022 Feb 9.
Alexander Egeberg 1, Nana Aviaaja Lippert Rosenø 2, David Aagaard 2, Erik Hillo Lørup 2, Mia-Louise Nielsen 2, Lea Nymand 2, Lars Erik Kristensen 3, Jacob P Thyssen 2, Simon Francis Thomsen 2, Rene Lindholm Cordtz 4, Nikolai Loft 5, Lone Skov 6, Lars Erik Bryld 7, Mads Kirchheiner Rasmussen 8, Pil Højgaard 9, Salome Kristensen 4, Lene Dreyer 10 |
| 29 | |
Sex-Based Medicine Meets Psoriatic Arthritis: Lessons Learned and to Learn |
Front Immunol. 2022 Apr 22;13:849560. doi: 10.3389/fimmu.2022.849560.eCollection 2022.
Nicola Luigi Bragazzi 1 2 3, Charlie Bridgewood 3, Abdulla Watad 3 4 5, Giovanni Damiani 6, Dennis McGonagle 3 7 |
| 30 | |
Real-life efficacy of guselkumab in patients with early psoriatic arthritis |
Rheumatology (Oxford). 2022 Mar 2;61(3):1217-1221.doi: 10.1093/rheumatology/keab509.
Ilenia Pantano 1, Daniele Mauro 1, Francesca Romano 2, Alessio Gambardella 2, Mario Valenti 3 4, Davide Simone 1, Daniela Iacono 1, Antonio Costanzo 3 4, Giuseppe Argenziano 2, Francesco Ciccia 1 |
| 31 | |
Advances of Genomic Medicine in Psoriatic Arthritis |
J Pers Med. 2022 Jan 3;12(1):35. doi: 10.3390/jpm12010035.
Carlos M Laborde 1, Leyre Larzabal 1, Álvaro González-Cantero 2 3, Patricia Castro-Santos 4, Roberto Díaz-Peña 5 |
| 32 | |
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis |
Ann Rheum Dis. 2022 Jun;81(6):815-822.doi: 10.1136/annrheumdis-2021-221664. Epub 2022 Mar 3.
Philip J Mease 1, Atul A Deodhar 2, Désirée van der Heijde 3, Frank Behrens 4, Alan J Kivitz 5, Jeffrey Neal 6, Jonghyeon Kim 7, Shalabh Singhal 7, Miroslawa Nowak 7, Subhashis Banerjee 7 |
| 33 | |
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials |
Clin Rheumatol. 2022 Feb;41(2):499-511. doi: 10.1007/s10067-021-05894-2.Epub 2021 Sep 12.
Alan J Kivitz 1, Oliver FitzGerald 2, Peter Nash 3, Shirley Pang 4, Valderilio F Azevedo 5, Cunshan Wang 6, Liza Takiya 7 |
| 34 | |
Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence |
Rheumatol Ther. 2022 Jun;9(3):803-821. doi: 10.1007/s40744-022-00443-y.Epub 2022 Apr 12.
Laura C Coates 1, Maarten de Wit 2, Amy Buchanan-Hughes 3, Maartje Smulders 4 5, Anna Sheahan 6, Alexis R Ogdie 7 |
| 35 | |
Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis |
Dermatology. 2022 May 12;1-12. doi: 10.1159/000524231.Online ahead of print.
Juliëtte N Pouw 1 2, Marleen E Jacobs 1, Deepak M W Balak 3, Jacob M van Laar 1, Paco M J Welsing 1, Emmerik F A Leijten 1 2 |
| 36 | |
Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis |
Rheumatology (Oxford). 2022 Apr 11;61(4):1328-1340.doi: 10.1093/rheumatology/keab774.
Gian Luca Erre 1 2, Dimitris Mavridis 3, Richard John Woodman 4, Arduino Aleksander Mangoni 5 6 |
| 38 | |
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE |
Rheumatology (Oxford). 2022 May 5;61(5):1867-1876.doi: 10.1093/rheumatology/keab628.
Maria Antonietta D'Agostino 1, Georg Schett 2 3, Alejandra López-Rdz 4, Ladislav Šenolt 5, Katalin Fazekas 6, Ruben Burgos-Vargas 7, Jose Maldonado-Cocco 8, Esperanza Naredo 9, Philippe Carron 10 11, Anne-Marie Duggan 12, Punit Goyanka 13, Maarten Boers 14, Corine Gaillez 15 |
| 39 | |
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial |
Ann Rheum Dis. 2022 Mar;81(3):351-358.doi: 10.1136/annrheumdis-2021-221048. Epub 2021 Nov 23.
Andrew Östör 1, Filip Van den Bosch 2, Kim Papp 3, Cecilia Asnal 4, Ricardo Blanco 5, Jacob Aelion 6, Gabriela Alperovich 7, Wenjing Lu 7, Zailong Wang 7, Ahmed M Soliman 7, Ann Eldred 7, Lisa Barcomb 7, Alan Kivitz 8 9 |
| 40 | |
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial |
Ann Rheum Dis. 2022 Feb;81(2):225-231.doi: 10.1136/annrheumdis-2021-221019. Epub 2021 Dec 15.
Lars Erik Kristensen 1, Mauro Keiserman 2, Kim Papp 3, Leslie McCasland 4, Douglas White 5, Wenjing Lu 6, Zailong Wang 6, Ahmed M Soliman 6, Ann Eldred 6, Lisa Barcomb 6, Frank Behrens 7 |
| 41 | |
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) |
Ann Rheum Dis. 2022 Mar;81(3):359-369.doi: 10.1136/annrheumdis-2021-220991. Epub 2021 Nov 24.
Laura C Coates 1, Laure Gossec 2 3, Elke Theander 4, Paul Bergmans 5, Marlies Neuhold 6, Chetan S Karyekar 7, May Shawi 8, Wim Noël 6, Georg Schett 9, Iain B McInnes 10 |
| 42 | |
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis |
J Rheumatol. 2021 Dec;48(12):1815-1823. doi: 10.3899/jrheum.201532.Epub 2021 May 1.
Proton Rahman 1, Christopher T Ritchlin 2, Philip S Helliwell 3, Wolf-Henning Boehncke 4, Philip J Mease 5, Alice B Gottlieb 6, Shelly Kafka 7, Alexa P Kollmeier 8, Elizabeth C Hsia 9, Xie L Xu 8, May Shawi 10, Shihong Sheng 11, Prasheen Agarwal 11, Bei Zhou 11, Paraneedharan Ramachandran 11, Yanli Zhuang 11, Iain B McInnes 12 |
| 43 | |
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies |
Rheumatology (Oxford). 2021 Nov 3;60(11):5337-5350.doi: 10.1093/rheumatology/keab285.
Dennis McGonagle 1, Iain B McInnes 2, Atul Deodhar 3, Georg Schett 4, May Shawi 5, Shelly Kafka 6, Chetan S Karyekar 5, Alexa P Kollmeier 7, Elizabeth C Hsia 8 9, Xie L Xu 7, Shihong Sheng 10, Prasheen Agarwal 10, Bei Zhou 10, Christopher T Ritchlin 11, Proton Rahman 12, Philip J Mease 13 |
| 44 | |
Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis |
Arthritis Rheumatol. 2022 Mar;74(3):475-485. doi: 10.1002/art.42010.Epub 2022 Feb 7.
Iain B McInnes 1, Proton Rahman 2, Alice B Gottlieb 3, Elizabeth C Hsia 4, Alexa P Kollmeier 5, Xie L Xu 5, Yusang Jiang 6, Shihong Sheng 6, May Shawi 7, Soumya D Chakravarty 8, Désirée van der Heijde 9, Philip J Mease 10 |
| 45 | |
Association of Cardiac Biomarkers with Cardiovascular Outcomes in Patients with Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study |
Arthritis Rheumatol. 2022 Mar 8. doi: 10.1002/art.42079. Online ahead of print.
Keith Colaco 1 2 3, Ker-Ai Lee 4, Shadi Akhtari 1 2, Raz Winer 5, Paul Welsh 6, Naveed Sattar 6, Iain B McInnes 6, Vinod Chandran 2 3, Paula Harvey 1 2, Richard J Cook 4, Dafna D Gladman 2 3, Vincent Piguet 1 2, Lihi Eder 1 2 |
| 46 | |
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients |
Rheumatology (Oxford). 2022 Mar 2;61(3):1035-1043.doi: 10.1093/rheumatology/keab449.
Alvin F Wells 1, Christopher J Edwards 2, Alan J Kivitz 3, Paul Bird 4, Benoit Guerette 5, Nikolay Delev 6, Maria Paris 5, Lichen Teng 5, Jacob A Aelion 7 |
| 47 | |
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey |
Rheumatol Ther. 2022 Mar 17. doi: 10.1007/s40744-022-00435-y. Online ahead of print. Pascal Richette 1, Laura C Coates 2, Valderilio F Azevedo 3, Joseph C Cappelleri 4, Jade Moser 5, Ruben Queiro-Silva 6, Lara Fallon 7, Meriem Kessouri 8 |
| 48 | |
Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis |
J Rheumatol. 2022 Mar 15;jrheum.211329. doi: 10.3899/jrheum.211329. Online ahead of print. Peter Nash 1 |
| 49 | |
Psoriatic arthritis: prospects for the future |
Ther Adv Musculoskelet Dis. 2022 Mar 28;14:1759720X221086710.doi: 10.1177/1759720X221086710. eCollection 2022. Simon Hackett 1, Alexis Ogdie 2, Laura C Coates 3 |
| 50 | |
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database |
JAMA Dermatol. 2022 Mar 23. doi: 10.1001/jamadermatol.2022.0364. Online ahead of print. Laura Pina Vegas 1 2, Laetitia Penso 1 3, Pascal Claudepierre 1 2, Emilie Sbidian 1 4 5 |
| 51 | |
Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes |
RMD Open. 2022 Mar;8(1):e002074. doi: 10.1136/rmdopen-2021-002074. Iain B McInnes 1, Laura M Sawyer 2, Kristen Markus 3, Corinne LeReun 4, Celia Sabry-Grant 3, Philip S Helliwell 5 |
| 52 | |
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials |
RMD Open. 2022 Mar;8(1):e002049. doi: 10.1136/rmdopen-2021-002049. Iain B McInnes 1, Andrew J K Ostor 2 3, Philip J Mease 4, William Tillett 5, Xenofon Baraliakos 6, Kurt de Vlam 7, Louis Bessette 8, Ralph Lippe 9, Anna Maniccia 10, Dai Feng 10, Tianming Gao 10, Patrick Zueger 10, Christopher Saffore 10, Koji Kato 10, In-Ho Song 10, Atul Deodhar 11 |
| 53 | |
Correlation of patient-reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis |
Int J Rheum Dis. 2022 Mar 25. doi: 10.1111/1756-185X.14310. Online ahead of print. Louise Ward 1, Michael Oliffe 2, Barry Kane 1, Diana Chessman 2, Donna Meaney 1, Fiona Briggs 2, Kathryn Gibson 2 3, Les Barnsley 1 4, Daniel Sumpton 1 5 |
| 54 | |
Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis |
Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab086. doi: 10.1093/rap/rkab086. eCollection 2021. Sayam R Dubash 1 2, Oras A Alabas 2 3, Xabier Michelena 2 4, Leticia Garcia-Montoya 1 2, Gabriele De Marco 1 2, Mira Merashli 5, Richard J Wakefield 1 2, Paul Emery 1 2, Dennis McGonagle 1 2, Ai Lyn Tan 1 2, Helena Marzo-Ortega 1 2 |
| 55 | |
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis |
Joint Bone Spine. 2022 Jan 14;89(3):105344. doi: 10.1016/j.jbspin.2022.105344.Online ahead of print. Daniel Wendling 1, Sophie Hecquet 2, Olivier Fogel 3, Jean-Guillaume Letarouilly 4, Frank Verhoeven 2, Thao Pham 5, Clément Prati 2, Anna Molto 6, Philippe Goupille 7, Emmanuelle Dernis 8, Alain Saraux 9, Adeline Ruyssen-Witrand 10, Cédric Lukas 11, Corinne Miceli-Richard 3, Christophe Hudry 12, Pascal Richette 13, Maxime Breban 14, Laure Gossec 15, Maxime Dougados 16, Pascal Claudepierre 17 |
| 56 | |
Endometriosis, psoriasis and psoriatic arthritis: A prospective cohort study |
Am J Epidemiol. 2022 Jan 13;kwac009. doi: 10.1093/aje/kwac009. Online ahead of print. Holly R Harris 1 2, Karen Moreno Nascimento Korkes 3, Tricia Li 4 5, Marina Kvaskoff 6, Eunyoung Cho 4 5 7, Luiz Fernando Carvalho 3, Abrar A Qureshi 4 5 8, Mauricio Abrao 3 9, Stacey A Missmer 10 11 |
| 57 | |
Clinical Controversies in Psoriatic Disease: The Use of IL-17i/IL-23i Versus TNFi as First-line Advanced Therapy in Psoriatic Arthritis |
J Rheumatol. 2022 Feb 15;jrheum .211325. doi: 10.3899/jrheum.211325. Online ahead of print. Deepak R Jadon 1, Arthur Kavanaugh 1, Ying Ying Leung 1 |
| 58 | |
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) |
J Rheumatol. 2022 Feb 15;jrheum.211317. doi: 10.3899/jrheum.211317. Online ahead of print. Kristina Callis Duffin 1, Dafna D Gladman 1, Niti Goel 1, Alice B Gottlieb 1, Oliver FitzGerald 1, Lynne V McFarland 1 |
| 59 | |
Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis |
Rheumatol. 2022 Feb 15;jrheum.211321. doi: 10.3899/jrheum.211321. Online ahead of print. Erik Lubberts 1, Jose U Scher 1, Oliver FitzGerald 1 |
| 60 | |
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group |
J Rheumatol. 2022 Feb 15;jrheum.211322. doi: 10.3899/jrheum.211322. Online ahead of print. Anna Antony 1, Richard Holland 1, Ashish J Mathew 1, Maria-Antoinetta D'Agostino 1, Walter P Maksymowych 1, Philip J Mease 1, Niti Goel 1, Alexis Ogdie 1, Laura C Coates 1, Vibeke Strand 1, Robin Christensen 1, Dafna D Gladman 1, Ana-Maria Orbai 1, Ying Ying Leung 1, William Tillett 1 |
| 61 | |
Current Medication Practices and Preferences Among Patients With Psoriatic Arthritis |
Clin Rheumatol. 2022 Mar 1;28(2):55-61. doi: 10.1097/RHU.0000000000001799. Monica Schwartzman 1, Zafir Abutalib 2, Lisa A Mandl |
| 62 | |
COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls |
J Rheumatol. 2022 Feb 1;jrheum.211012. doi: 10.3899/jrheum.211012. Online ahead of print. Lihi Eder 1, Ruth Croxford 1, Aaron M Drucker 1, Arielle Mendel 1, Bindee Kuriya 1, Zahi Touma 1, Sindhu R Johnson 1, Richard Cook 1, Sasha Bernatsky 1, Nigil Haroon 1, Jessica Widdifield 1 |
| 63 | |
Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis |
Clin Rheumatol. 2022 Jan 27. doi: 10.1007/s10067-021-06045-3. Online ahead of print. Guy Katz 1, Alexis Ogdie 2, Joshua F Baker 3, Michael D George 2 |
| 64 | |
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists |
Clin Rheumatol. 2022 Jan 26;1-13. doi: 10.1007/s10067-022-06077-3.Online ahead of print. |
| 65 | |
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia |
BMC Rheumatol. 2022 Jan 27;6(1):5.doi: 10.1186/s41927-021-00235-x. Anat Fisher 1, Jason D Kim 2, Greg Carney 2, Colin Dormuth 2 |
| 66 | |
Pregnancy, delivery, and neonatal outcomes among women with psoriatic arthritis, a population based study |
J Perinat Med. 2022 Jan 21. doi: 10.1515/jpm-2021-0468. Online ahead of print. Ella M Gangbe 1, Ahmad Badeghiesh 2, Haitham Baghlaf 3, Michael H Dahan 4 |
| 67 | |
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo |
Arthritis Res Ther. 2022 Feb 9;24(1):40. doi: 10.1186/s13075-022-02721-0. Dafna D Gladman 1, Laura C Coates 2, Joseph Wu 3, Lara Fallon 4, Elizabeth D Bacci 5, Joseph C Cappelleri 3, Andrew G Bushmakin 3, Philip S Helliwell 6 |
| 68 | |
Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countries |
Int J Womens Dermatol. 2021 Aug 28;7(5Part B):697-707. doi: 10.1016/j.ijwd.2021.08.011.eCollection 2021 Dec. Sandy R McBride 1, Maria C Fargnoli 2, Anne-Claire Fougerousse 3, Marta García Bustínduy 4, Louise Catton 5, Lerzan Senturk 6, Cécile Ecoffet 6, Jan Koren 7, Laura Andreoli 8 9, Laura C Coates 10, Alice Titialii 11 |
| 69 | |
Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis - data from the Danish nationwide DANBIO registry |
Semin Arthritis Rheum. 2021 Dec 30;151948. doi: 10.1016/j.semarthrit.2021.12.012.Online ahead of print. Ashish J Mathew 1, Bente Glintborg 2, Niels Steen Krogh 3, Merete L Hetland 2, Mikkel Østergaard 2 |
| 70 | |
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study |
J Clin Med. 2021 Dec 29;11(1):180. doi: 10.3390/jcm11010180. Antonio Marchesoni 1, Pierluigi Macchioni 2, Stefania Gasparini 3, Carlo Perricone 4, Fabio Massimo Perrotta 5, Rosa Daniela Grembiale 6, Ettore Silvagni 7, Roberta Ramonda 8, Luisa Costa 9, Alen Zabotti 10, Giacomo Curradi 11, Giuliana Gualberti 11, Francesca Marando 11, Carlo Salvarani 2 |
| 71 | |
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) |
Ther Adv Musculoskelet Dis. 2021 Dec 18;13:1759720X211057975.doi: 10.1177/1759720X211057975. eCollection 2021. Denis Poddubnyy 1, Xenofon Baraliakos 2, Filip Van den Bosch 3, Jürgen Braun 2, Laura C Coates 4, Vinod Chandran 5, Torsten Diekhoff 6, Floris A van Gaalen 7, Lianne S Gensler 8, Niti Goel 9, Alice B Gottlieb 10, Désirée van der Heijde 7, Philip S Helliwell 11, Kay Geert A Hermann 6, Deepak Jadon 12, Robert G Lambert 13, Walter P Maksymowych 14, Philip Mease 15, Peter Nash 16, Fabian Proft 17, Mikhail Protopopov 17, Joachim Sieper 17, Murat Torgutalp 17, Dafna D Gladman 5 |
| 73 | |
Medication interruptions and subsequent disease flares during the COVID-19 pandemic: a longitudinal online study of patients with rheumatic disease |
Arthritis Care Res (Hoboken). 2021 Dec 10. doi: 10.1002/acr.24837. Online ahead of print. Tiffany Dharia 1, Shilpa Venkatachalam 2, Joshua F Baker 1, Shubhasree Banerjee 1, David Curtis 2, Maria I Danila 3, Kelly Gavigan 2, Jennifer Gordon 4, Peter A Merkel 1, Dianne G Shaw 5, Kalen Young 5, Jeffrey R Curtis 3, William B Nowell 2, Michael D George 1 |
| 74 | |
Economic burden of joint analysis in psoriasis: US claims analysis |
Am J Manag Care. 2021 Dec 1;27(12):e406-e412. doi: 10.37765/ajmc.2021.88768. Patricia Prince 1, Michelle Skornicki, Robert Suruki, Edward Lee, Anthony Louder |
| 75 | |
The relationship between the nail and systemic enthesitis in psoriatic arthritis |
Rheumatol Adv Pract. 2021 Nov 19;5(3):rkab088. doi: 10.1093/rap/rkab088. eCollection 2021. Ashley Elliott 1, Adrian Pendleton 2, Gary Wright 2, Madeleine Rooney 1 |
| 76 | |
Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR) |
Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab085. doi: 10.1093/rap/rkab085. eCollection 2021. Alla Ishchenko 1 2, Johan Joly 2, Barbara Neerinckx 1 2, Rik Lories 1 2, Kurt de Vlam 1 2 |
| 77 | |
The Digital Way to Intercept Psoriatic Arthritis |
Front Med (Lausanne). 2021 Nov 23;8:792972. doi: 10.3389/fmed.2021.792972.eCollection 2021. Ivan Giovannini 1, Philipp Bosch 2, Christian Dejaco 3, Gabriele De Marco 4, Dennis McGonagle 4, Luca Quartuccio 1, Salvatore De Vita 1, Enzo Errichetti 5, Alen Zabotti 1 |
| 78 | |
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance |
J Rheumatol. 2021 Sep 1;jrheum.210480. doi: 10.3899/jrheum.210480. Online ahead of print. Bonnie L Bermas 1, Milena Gianfrancesco 1, Helen L Tanner 1, Andrea M Seet 1, Mathia C Aguiar 1, Nasra K Al Adhoubi 1, Samar Al Emadi 1, Bernardo M Cunha 1, Rachael Flood 1, Daria A Kusevich 1, Eoghan M McCarthy 1, Naomi J Patel 1, Eric Ruderman 1, Sebastian E Sattui 1, Savino Sciascia 1, Faizah Siddique 1, Maria O Valenzuela-Almada 1, Leanna M Wise 1, Angus B Worthing 1, JoAnn Zell 1, Suleman Bhana 1, Wendy Costello 1, Ali Duarte-Garcia 1, Rebecca Grainger 1, Laure Gossec 1, Jonathan S Hausmann 1, Kimme Hyrich 1, Saskia Lawson-Tovey 1, Jean W Liew 1, Emily Sirotich 1, Jeffrey A Sparks 1, Paul Sufka 1, Zachary S Wallace 1, Pedro M Machado 1, Anja Strangfeld 1, Megan E B Clowse 1, Jinoos Yazdany |
| 79 | |
Digital Approaches for a Reliable Early Diagnosis of Psoriatic Arthritis |
Front Med (Lausanne). 2021 Aug 11;8:718922. doi: 10.3389/fmed.2021.718922.eCollection 2021. Filippo Fagni 1 2, Johannes Knitza 1 2, Martin Krusche 3, Arnd Kleyer 1 2, Koray Tascilar 1 2, David Simon 1 2 |
| 80 | |
Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study |
Arthritis Rheumatol. 2021 Aug 23. doi: 10.1002/art.41946. Online ahead of print. Yael Shalev Rosenthal 1, Naama Schwartz 2, Iftach Sagy 3 4, Lev Pavlovsky 1 5 |
| 81 | |
PsAID High-impact Disease in Psoriatic Arthritis: A Component Weighting Analysis of the Assessment of SpondyloArthritis international Society Health Index |
J Rheumatol. 2021 Aug 15;jrheum.210377. doi: 10.3899/jrheum.210377. Online ahead of print. |
| 82 | |
Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2021 Sep 1;jrheum.210469. doi: 10.3899/jrheum.210469. Online ahead of print. |
| 83 | |
Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores |
Clin Trials. 2021 Aug 25;17407745211023840. doi: 10.1177/17407745211023840.Online ahead of print. Sarah M Weinstein 1, Laura C Coates 2, Philip S Helliwell 3, Alexis Ogdie 1 4, Alisa J Stephens-Shields 1 |
| 84 | |
Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results |
J Rheumatol. 2021 May;48(5):693-697. doi: 10.3899/jrheum.191209. Epub 2020 Nov 15. Alexis Ogdie 1, Mei Liu 2, Meghan Glynn 2, Kelechi Emeanuru 2, Leslie R Harrold 3, Sven Richter 4, Benoit Guerette 4, Philip J Mease 5 |
| 85 | |
Risk of Osteoarthritis in an Incident Cohort of People With Psoriatic Arthritis: A Population-based Cohort Study |
J Rheumatol. 2021 Jun;48(6):841-846. doi: 10.3899/jrheum.200564. Epub 2020 Nov 15. Rachel A Charlton 1, Amelia Green 1, Gavin Shaddick 2, Julia Snowball 1, Alison Nightingale 1, William Tillett 3, Catherine Smith 4, Neil J McHugh, PROMPT Study Group |
| 86 | |
Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database |
Drugs Real World Outcomes. 2021 Mar;8(1):29-38. doi: 10.1007/s40801-020-00217-4.Epub 2020 Nov 12. Peter Hur 1, Nina Kim 2 3, Dong Dai 4, Olivia W Piao 5, Josh Z Zheng 5, Esther Yi 4 |
| 87 | |
Does age matter in Psoriatic arthritis? A narrative review |
J Rheumatol. 2021 Aug 15;jrheum.210349. doi: 10.3899/jrheum.210349. Online ahead of print. George E Fragoulis 1, Elena Nikiphorou 1, Iain B McInnes 1, Stefan Siebert 1 |
| 88 | |
Are fatty acids associated with disease activity and biomarkers in patients with psoriatic arthritis? Data from a multicenter clinical trial |
Rheumatol Int. 2021 Jul 29. doi: 10.1007/s00296-021-04953-w. Online ahead of print. Salome Kristensen 1 2, Signe Holm Nielsen 3 4, Erik Berg Schmidt 5 6, Anne Christine Bay-Jensen 3, Morten A Karsdal 3, Jeppe Hagstrup Christensen 5 7 |
| 89 | |
Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study |
ACR Open Rheumatol. 2020 Nov;2(11):640-647. doi: 10.1002/acr2.11180. Epub 2020 Oct 19. Philip Mease 1, M Elaine Husni 2, Soumya D Chakravarty 3, Shelly Kafka 4, Dennis Parenti 4, Lilianne Kim 5, Kim Hung Lo 5, Elizabeth C Hsia 6, Arthur Kavanaugh 7 |
| 90 | |
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials |
Ann Rheum Dis. 2021 Feb;80(2):185-193.doi: 10.1136/annrheumdis-2019-216835. Epub 2020 Oct 26. Philip J Mease 1, Philip S Helliwell 2, Kasper Fjellhaugen Hjuler 3, Kyle Raymond 4, Iain McInnes 5 |
| 91 | |
Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity - a cross-sectional study |
Rheumatology (Oxford). 2021 Apr 6;60(4):1858-1862. doi: 10.1093/rheumatology/keaa604. Lyn D Ferguson 1, Jennifer Linge 2 3, Olof Dahlqvist Leinhard 2 3, Rosemary Woodward 4, Pauline Hall Barrientos 4, Giles Roditi 4, Aleksandra Radjenovic 1, Iain B McInnes 5, Stefan Siebert 5, Naveed Sattar 1 |
| 92 | |
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study |
RMD Open. 2021 Jul;7(2):e001600. doi: 10.1136/rmdopen-2021-001600. Philip J Mease 1, Robert Landewé 2 3, Proton Rahman 4, Hasan Tahir 5, Atul Singhal 6, Elke Boettcher 7, Sandra Navarra 8, Aimee Readie 9, Shephard Mpofu 10, Eumorphia Maria Delicha 10, Luminita Pricop 9, Desirée van der Heijde 11 |
| 93 | |
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis |
Curr Ther Res Clin Exp. 2020 Aug 12;93:100601. doi: 10.1016/j.curtheres.2020.100601.eCollection 2020. Dafna D Gladman 1, Ana-Maria Orbai 2, Juan Gomez-Reino 3, Stacey Chang-Douglass 4, Emanuele Leoncini 4, Hannah E Burton 4, Keith S Kanik 5, Ana Belen Romero 6, Joseph C Cappelleri 5, Ming-Ann Hsu 5 |
| 94 | |
Multimorbidity and comorbidity in psoriatic arthritis - a perspective |
Expert Rev Clin Immunol. 2020 Oct;16(10):963-972 doi:10.1080/1744666X.2021.1825941.Epub 2020 Oct 3. Ennio Lubrano 1, Silvia Scriffignano 1, Fabio Massimo Perrotta 1 |
| 95 | |
Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health |
Rheumatol Adv Pract. 2020 Jul 11;4(2):rkaa028. doi: 10.1093/rap/rkaa028. eCollection 2020. Kate Carter 1, Caterina Tannous 2, Steven Walmsley 1, Keith Rome 3, Deborah E Turner 1 4 |
| 96 | |
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies |
ACR Open Rheumatol. 2020 Oct;2(10):543-554. doi: 10.1002/acr2.11166. Epub 2020 Sep 10. Christopher T Ritchlin 1, Jon T Giles 2, Alexis Ogdie 3, Juan J Gomez-Reino 4, Philip Helliwell 5, Pamela Young 6, Cunshan Wang 7, Joseph Wu 7, Ana Belén Romero 8, John Woolcott 6, Lori Stockert 6 |
| 97 | |
Histological Evaluation of the Relationships Between Distal Interphalangeal Psoriatic Arthritis and Nail Psoriasis: Correlations With Anatomical Studies of the Normal Nail Unit and the Main Radiological Data Concerning Distal Interphalangeal Psoriatic Arthritis |
Am J Dermatopathol. 2020 Dec;42(12):911-915. doi: 10.1097/DAD.0000000000001786. |
| 98 | |
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis |
Rheumatology (Oxford). 2021 Mar 2;60(3):1137-1147. doi: 10.1093/rheumatology/keaa271. Laura C Coates 1, Joseph F Merola 2, Philip J Mease 3, Alexis Ogdie 4, Dafna D Gladman 5, Vibeke Strand 6, Leonieke J J van Mens 7, Lyrica Liu 8, Priscilla K Yen 9, David H Collier 10, Gregory Kricorian 10, James B Chung 10, Philip S Helliwell 11 |
| 99 | |
Barriers to shared decision-making with women of reproductive age affected by a chronic inflammatory disease: a mixed-methods needs assessment of dermatologists and rheumatologists |
BMJ Open. 2021 Jun 16;11(6):e043960. doi: 10.1136/bmjopen-2020-043960. Suzanne Murray 1, Monica Augustyniak 2, Jenny E Murase 3 4, Rebecca Fischer-Betz 5, Catherine Nelson-Piercy 6, Morgan Peniuta 2, Ivo Vlaev 7 |
| 100 | |
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFa, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study |
Clin Rheumatol. 2021 Jun 16. doi: 10.1007/s10067-021-05799-0. Online ahead of print. Mariagrazia Lorenzin # 1, Augusta Ortolan # 1, Giacomo Cozzi 1, Antonia Calligaro 1, Maria Favaro 1, Teresa Del Ross 1, Andrea Doria 1, Roberta Ramonda 2 |
| 101 | |
Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index |
Arthritis Care Res (Hoboken). 2020 Aug 29;10.1002/acr.24433. doi: 10.1002/acr.24433.Online ahead of print. Erin Chew 1 2, Jamie Perin 3, Thomas Grader-Beck 1, Ana-Maria Orbai 1 |
| 102 | |
Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates |
Arthritis Res Ther. 2020 Aug 26;22(1):198. doi: 10.1186/s13075-020-02294-w. Glenn Haugeberg 1 2, Mari Hoff 3, Arthur Kavanaugh 4, Brigitte Michelsen 5 |
| 103 | |
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration |
Ann Rheum Dis. 2021 Jun 3;annrheumdis-2021-220097.doi: 10.1136/annrheumdis-2021-220097. Online ahead of print. Ulf Lindström 1, Daniela Di Giuseppe 2, Bénédicte Delcoigne 2, Bente Glintborg 3 4, Burkhard Möller 5, Adrian Ciurea 6, Manuel Pombo-Suarez 7, Carlos Sanchez-Piedra 8, Kari Eklund 9 10, Heikki Relas 9, Bjorn Gudbjornsson 11 12, Thorvardur Jon Love 12 13, Gareth T Jones 14, Catalin Codreanu 15, Ruxandra Ionescu 16, Lucie Nekvindova 17 18, Jakub Závada 19 20, Nuh Atas 21, Servet Yolbas 22, Karen Minde Fagerli 23, Brigitte Michelsen 23 24, Žiga Rotar 25 26, Matija Tomšic 25 26, Florenzo Iannone 27, Maria Jose Santos 28, Pedro Avila-Ribeiro 29 30, Lykke Midtbøll Ørnbjerg 31, Mikkel Østergaard 31 32, Lennart Th Jacobsson 33, Johan Askling 2, Michael J Nissen 34 |
| 104 | |
Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis |
Int J Rheum Dis. 2021 Jun 2. doi: 10.1111/1756-185X.14147. Online ahead of print. Aravinthan Loganathan 1 2 3, Narainraj Kamalaraj 1 4, Carlos El-Haddad 1, Kevin Pile 1 3 |
| 105 | |
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting |
J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681. Laura C Coates 1, Nadia Corp 2, Danielle A van der Windt 2, Enrique R Soriano 3, Arthur Kavanaugh 4 |
| 106 | |
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting |
J Rheumatol Suppl. 2021 Jun;97:64. doi: 10.3899/jrheum.201680. |
| 107 | |
Development of a national survey on foot involvement among people with psoriatic arthritis in Australia using a best practice approach: a survey development protocol |
J Foot Ankle Res. 2020 Aug 26;13(1):53. doi: 10.1186/s13047-020-00424-w. Kate Carter 1, Steven Walmsley 2, Keith Rome 3, Deborah E Turner 4 |
| 108 | |
Development and Validation of a Sonographic Enthesitis Instrument in Psoriatic Arthritis: The GRAPPA Diagnostic Ultrasound Enthesitis Tool (DUET) Project |
J Rheumatol Suppl. 2020 Jun;96:50-52. doi: 10.3899/jrheum.200128. |
| 109 | |
JAK inhibitors, Psoriatic Arthritis, and Axial Spondyloarthritis: a Critical Review of Clinical Trials |
Expert Rev Clin Immunol. 2021 May 4. doi: 10.1080/1744666X.2021.1925541.Online ahead of print. |
| 110 | |
Updated therapies for the management of Psoriatic Arthritis |
Clin Immunol. 2020 Nov;220:108536. doi: 10.1016/j.clim.2020.108536.Epub 2020 Jul 16. Atrin Toussi 1, Natalia Maverakis 2, Stephanie T Le 3, Soumajyoti Sarkar 4, Smriti K Raychaudhuri 5, Siba P Raychaudhuri 6 |
| 111 | |
Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis |
J Rheumatol. 2021 Apr 15;jrheum.210175. doi: 10.3899/jrheum.210175. Online ahead of print. Ying Ying Leung 1, William Tillett 1, Pil Hojgaard 1, Ana-Maria Orbai 1, Richard Holland 1, Ashish J Mathew 1, Niti Goel 1, Jeffrey Chau 1, Chris Lindsay 1, Alexis Ogdie 1, Laura C Coates 1, Robin Christensen 1, Philip Mease 1, Vibeke Strand 1, Dafna D Gladman 1 |
| 112 | |
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes |
Semin Arthritis Rheum. 2021 Apr 15;51(3):530-538.doi: 10.1016/j.semarthrit.2021.04.003. Online ahead of print. Yvette Meissner 1, Tatjana Rudi 2, Rebecca Fischer-Betz 3, Anja Strangfeld 2 |
| 113 | |
The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data |
Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136. Online ahead of print. M Lebwohl 1, A Deodhar 2, C E M Griffiths 3, M A Menter 4, D Poddubnyy 5, W Bao 6, V Jehl 7, K Marfo 7, P Primatesta 7, A Shete 7, V Trivedi 6, P J Mease 8 |
| 114 | |
GRAPPA Treatment Recommendations: Updates and Methods |
J Rheumatol Suppl. 2020 Jun;96:41-45. doi: 10.3899/jrheum.200126. Arthur Kavanaugh 1 2, Laura C Coates 3 4, Danielle A van der Windt 3 4, Nadia Corp 3 4, Enrique R Soriano 3 4 |
| 115 | |
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study |
Rheumatol Ther. 2020 Sep;7(3):553-580.doi: 10.1007/s40744-020-00209-4. Epub 2020 Jun 6. Peter Nash 1, Laura C Coates 2, Alan J Kivitz 3, Philip J Mease 4, Dafna D Gladman 5, José A Covarrubias-Cobos 6, Oliver FitzGerald 7, Dona Fleishaker 8, Cunshan Wang 8, Joseph Wu 8, Ming-Ann Hsu 8, Sujatha Menon 8, Lara Fallon 9, Ana Belén Romero 10, Keith S Kanik 8 |
| 116 | |
Methotrexate in Psoriasis and Psoriatic Arthritis |
J Rheumatol Suppl. 2020 Jun;96:31-35. doi: 10.3899/jrheum.200124. Laura C Coates 1 2 3, Joseph F Merola 4 5 6, Suzanne M Grieb 4 5 6, Philip J Mease 4 5 6, Kristina Callis Duffin 4 5 6 |
| 117 | |
Resolution of Enthesitis by Guselkumab and Relationships to Disease Burden: 1-Year Results of Two Phase-3 Psoriatic Arthritis Studies |
Rheumatology (Oxford). 2021 Apr 6;keab285. doi: 10.1093/rheumatology/keab285.Online ahead of print. Dennis McGonagle 1, Iain B McInnes 2, Atul Deodhar 3, Georg Schett 4, May Shawi 5, Shelly Kafka 6, Chetan S Karyekar 5, Alexa P Kollmeier 7, Elizabeth C Hsia 7 8, Xie L Xu 7, Shihong Sheng 9, Prasheen Agarwal 9, Bei Zhou 9, Christopher T Ritchlin 10, Proton Rahman 11, Philip J Mease 12 |
| 118 | |
Current treatments and recommendations |
Best Pract Res Clin Rheumatol. 2021 Apr 3;101680. doi: 10.1016/j.berh.2021.101680.Online ahead of print. |
| 119 | |
Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2020 Jun 1;jrheum.191117. doi: 10.3899/jrheum.191117. Online ahead of print. Philip J Mease 1, Mei Liu 1, Sabrina Rebello 1, Winnie Hua 1, Robert R McLean 1, Peter Hur 1, Alexis Ogdie 1 |
| 120 | |
Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment? |
Dermatol Ther. 2020 Sep;33(5):e13743. doi: 10.1111/dth.13743. Epub 2020 Jun 30. Uwe Wollina 1, Massimo Fioranelli 2, Mohamad Goldust 3 4 5, Torello Lotti 6 |
| 121 | |
Not your average joint: Towards precision medicine in psoriatic arthritis |
Clin Immunol. 2020 Aug;217:108470. doi: 10.1016/j.clim.2020.108470.Epub 2020 May 28. |
| 122 | |
Evaluation of a Genetic Risk Score for Diagnosis of Psoriatic Arthritis |
J Psoriasis Psoriatic Arthritis. 2020 Apr;5(2):61-67. doi: 10.1177/2475530320910814.Epub 2020 Mar 4. Mary Patricia Smith 1, Karen Ly 1, Quinn Thibodeaux 1, Kristen Beck 1, Eric Yang 1 2, Isabelle Sanchez 1 3, Joanne Nititham 1, Tina Bhutani 1, Wilson Liao 1 |
| 123 | |
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis |
PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781.eCollection 2020. Johan Burisch 1, Wolfgang Eigner 2, Stefan Schreiber 3, Daniel Aletaha 4, Wolfgang Weninger 5, Michael Trauner 2, Walter Reinisch 2, Neeraj Narula 6 |
| 124 | |
Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States |
J Manag Care Spec Pharm. 2020 Aug;26(8):1027-1038. doi: 10.18553/jmcp.2020.19319.Epub 2020 Apr 20. George Bungey 1, Stacey Chang-Douglass 1, Ming-Ann Hsu 2, Joseph C Cappelleri 2, Pamela Young 3, John Woolcott 3 |
| 125 | |
Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies |
Curr Med Res Opin. 2020 Jul;36(7):1245-1252. doi: 10.1080/03007995.2020.1754186.Epub 2020 Apr 23. Jessica A Walsh 1, Qian Cai 2, Iris Lin 3, Timothy Fitzgerald 3, Christopher D Pericone 2, Soumya D Chakravarty 3 4 |
| 126 | |
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases |
J Rheumatol. 2021 Jan 1;48(1):48-57. doi: 10.3899/jrheum.190815. Epub 2020 Apr 1. Matthew L Thomas 1, Gavin Shaddick 2, Rachel Charlton 3, Charlotte Cavill 4, Richard Holland 4, Florenzo Iannone 5, Giovanni Lapadula 5, Simona Lopriore 5, Jakub Závada 6, Michal Uher 7, Karel Pavelka 6, Lenka Szczuková 7, Prodromos Sidiropoulos 8, Irini Flouri 8, Alexandros Drosos 9, Burkhard Möller 10, Michael J Nissen 11, Rüdiger B Müller 12, Almut Scherer 13, Neil McHugh 14, Alison Nightingale 15 |
| 127 | |
Psoriatic arthritis in childhood: A commentary on the controversy |
Clin Immunol. 2020 May;214:108396. doi: 10.1016/j.clim.2020.108396.Epub 2020 Mar 27. |
| 128 | |
Challenges in the clinical diagnosis of psoriatic arthritis |
Clin Immunol. 2020 May;214:108390. doi: 10.1016/j.clim.2020.108390.Epub 2020 Mar 18. |
| 129 | |
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial |
Lancet. 2020 Apr 4;395(10230):1126-1136.doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13. Philip J Mease 1, Proton Rahman 2, Alice B Gottlieb 3, Alexa P Kollmeier 4, Elizabeth C Hsia 5, Xie L Xu 4, Shihong Sheng 6, Prasheen Agarwal 6, Bei Zhou 6, Yanli Zhuang 7, Désirée van der Heijde 8, Iain B McInnes 9, DISCOVER-2 Study Group |
| 130 | |
Complexities in Genetics of Psoriatic Arthritis |
Curr Rheumatol Rep. 2020 Mar 12;22(4):10. doi: 10.1007/s11926-020-0886-x. Sara Rahmati 1 2, Lam Tsoi 3, Darren O'Rielly 1, Vinod Chandran 1 2 4 5 6, Proton Rahman 7 |
| 131 | |
Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis |
Rheumatology (Oxford). 2020 Sep 1;59(9):2199-2206.doi: 10.1093/rheumatology/keaa062. Bradley Pittam 1, Sonal Gupta 1, Nicholas L Harrison 2, Selina Robertson 1, David M Hughes 3, Sizheng Steven Zhao 2 4 |
| 132 | |
The many faces of psoriatic arthritis: their genetic determinism |
Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i4-i9.doi: 10.1093/rheumatology/kez325. |
| 133 | |
Ixekizumab for the treatment of psoriasis: up-to-date |
Expert Opin Biol Ther. 2020 Jun;20(6):549-557.doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10. |
| 134 | |
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis |
Rheumatol Int. 2020 Apr;40(4):511-521. doi: 10.1007/s00296-020-04526-3.Epub 2020 Feb 12. Stephan Pflugbeil 1, Karin Böckl 2, Reinhold Pongratz 1, Marianne Leitner 3, Winfried Graninger 4, Astrid Ortner 5 |
| 135 | |
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial |
Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1. Philip Mease 1, M Elaine Husni 2, Shelly Kafka 3, Soumya D Chakravarty 3 4, Diane D Harrison 5, Kim Hung Lo 5, Stephen Xu 5, Elizabeth C Hsia 5 6, Arthur Kavanaugh 7 |
| 136 | |
Identifying and Characterizing Psoriasis and Psoriatic Arthritis Patients in Ontario Administrative Data: A Population-based Study From 1991 to 2015 |
J Rheumatol. 2020 Nov 1;47(11):1644-1651. doi: 10.3899/jrheum.190659. Epub 2020 Feb 15. Lihi Eder 1, Jessica Widdifield 2, Cheryl F Rosen 3, Raed Alhusayen 4, Stephanie Y Cheng 5, Jacqueline Young 5, Willemina Campbell 6, Sasha Bernatsky 7, Dafna D Gladman 8, Michael Paterson 9, Karen Tu 10 |
| 137 | |
Remission in psoriatic arthritis: Definition and predictors |
Semin Arthritis Rheum. 2020 Dec;50(6):1494-1499. doi: 10.1016/j.semarthrit.2020.01.012.Epub 2020 Feb 3. Samar Alharbi 1, Justine Y Ye 2, Ker-Ai Lee 3, Vinod Chandran 4, Richard J Cook 3, Dafna D Gladman 5 |